StockNews.AI
NTRA
StockNews.AI
173 days

Natera Reports Fourth Quarter and Full Year 2024 Financial Results

1. Natera's Q4 2024 revenues rose 53% year-over-year, indicating strong growth. 2. Gross margin reached 62.9%, reflecting effective cost management.

Earnings
-0.65%Current Return
VS
+1.55%S&P 500
$156.6102/27 04:18 PM EDTEvent Start
$155.5902/28 10:47 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bullish?

Natera's significant revenue growth and solid gross margin position it favorably for investors. A similar past performance drove stock prices upwards in the biotech sector.

How important is it?

The quarterly results highlight Natera's growth momentum, directly relevant to its market performance. Investors often prioritize financial growth indicators when assessing stock potential.

Why Short Term?

Immediate investor reactions to strong quarterly results typically drive stock prices rapidly. Historically, positive earnings surprises boost stock performance in the following weeks.

Related Companies

ILMNCDNAMGEN
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today reported its financial results for the fourth quarter and full year ended December 31, 2024. Recent Financial Highlights Generated total revenues of $476.1 million in the fourth quarter of 2024, compared to $311.1 million in the fourth quarter of 2023, an increase of 53.0%. Product revenues grew 53.9% over the same period. Generated a gross margin of 62.9% in the fourth quart.

Related News